Clinical trial

Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer

NCT06197581

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-01-12

PhaseNA

Study timeline

Study start (actual)2024-01-12Date precision: day

Registry last updated2024-08-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer, Familial Maleunresolved

Radiotherapy; Complicationsunresolved

Chemotherapeutic Toxicityunresolved

Immune Checkpoint Inhibitorunresolved

CDK4/6 Inhibitorunresolved

Trastuzumabunresolved

Pertuzumabunresolved

PARP Inhibitorunresolved

Interventions

Chest wall / breast radiation with or without lymph node region radiation.(For all of the enrolled patients)RADIATION

Sponsors & collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Scienceslead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06197581 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.